Complications of Diabetes: Retinopathy Screening and Management

Complications of Diabetes: Retinopathy Screening and Management

EndocrinologyFamily MedicineGeneral PracticeInternal MedicineOphthalmology
A badge with ribbon in color black No CME/CPD credits | An analog clock in color black 1 hour | A black calendar with white triangle in center that has a black exclamation point in the middle 19 Jan 2027 

Overview

About

Diabetic retinopathy is one of the most common and vision-threatening outcomes of long-standing diabetes, representing a key marker of systemic microvascular injury. As rates of type 2 diabetes continue to rise globally, the prevalence of this condition has increased in parallel, making retinal disease in diabetes a growing clinical and public health priority. Understanding its pathophysiology, natural history, and risk factors is crucial for effective prevention and timely detection.

Retinal disease in diabetes develops gradually, driven by chronic hyperglycemia, hypertension, and metabolic dysregulation that damage retinal microvasculature. Over time, patients may progress from mild non-proliferative changes to advanced proliferative disease or diabetic macular edema, each carrying significant risks for irreversible vision loss. Recognizing the early structural and functional changes is essential to prevent progression to late-stage complications.

Diabetic retinopathy screening plays a pivotal role in identifying disease during its asymptomatic phase. Modern screening strategies include dilated fundus examination, retinal photography, and other automated assessments. Evidence consistently shows that early detection significantly reduces blindness risk and improves long-term visual outcomes.

Advances in diabetic retinopathy treatment—from laser photocoagulation and intravitreal anti- vascular endothelial growth factor (VEGF) therapy to corticosteroid options—have transformed prognosis and preserved sight for many patients. Integrating these ophthalmic interventions with systemic risk-factor control, patient education, and coordinated multidisciplinary care is vital to comprehensive diabetes complications management. These combined approaches reflect the evolving landscape of evidence-based care for patients living with diabetes.

This lecture provides a detailed exploration of current concepts in diabetic retinopathy, including disease mechanisms, contemporary screening approaches, and effective management strategies aimed at preventing vision loss and improving patient outcomes.

Learning outcomes

At the end of this learning activity, participants should be able to:

  • Describe the global burden of diabetes and its impact on microvascular complications.
  • Identify key factors associated with the development and progression of microvascular complications, with emphasis on diabetic retinopathy.
  • Explain the pathophysiology, epidemiology, and risk factors of diabetic retinopathy.
  • Apply appropriate guidelines for screening initiation, staging, and diagnostic evaluation of diabetic retinopathy.
  • Integrate evidence-based strategies for the management of diabetic retinopathy into primary care practice.

Topics covered

    I. Introduction: Diabetes and Microvascular Complications
    • Global burden of disease
    • Importance of early recognition
    • Associated factors of developing microvascular complications
    II. Diabetic Retinopathy: Overview
    • Epidemiology
    • Risk factors
    • Pathophysiology
    • Public Health Challenge: Patient Awareness
    III. Screening and Diagnosis
    • Screening
    • History and physical examination
    • Ancillary tests
    • Staging
    • Screening intervals
    • Referral
    IV. Management

This module was created in collaboration with:

Dr Kristen image-KOL.png

KRISTINE G. PORMIDA, MD, DPBO
GENERAL OPHTHALMOLOGY, VITREO RETINAL SPECIALIST

Keywords: diabetic retinopathy, retinal disease in diabetes, diabetic retinopathy screening, diabetic retinopathy treatment, diabetes complications management

Something went wrong.